UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Epidemiology, clinical manifestations, and diagnosis of melioidosis

Authors
Bart Currie, MBBS, FRACP
Nicholas Anstey, MBBS, FRACP
Section Editor
Daniel J Sexton, MD
Deputy Editor
Allyson Bloom, MD

INTRODUCTION

Melioidosis is an infection caused by the facultative intracellular gram-negative bacterium, Burkholderia pseudomallei [1-3]. This organism is a widely distributed environmental saprophyte in soil and fresh surface water in endemic regions [4].

The epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis will be presented here. The treatment and prognosis of this disease are discussed separately. (See "Treatment and prognosis of melioidosis".)

EPIDEMIOLOGY

Geographic distribution — Melioidosis occurs predominantly in Southeast Asia, northern Australia, South Asia (including India), and China (figure 1) [2,5-8]. The majority of diagnosed cases are from Thailand [9-12], Malaysia [13-16], Singapore [17-23], and northern Australia [24-26]. Cases are also reported from Papua New Guinea [27] and New Caledonia [28]. Northeastern Thailand and parts of northern Australia are "hyperendemic" for melioidosis [10,24], with seasonal peaks in the wet seasons. In 2010, there was been an increase in incidence in both northeast Thailand and northern Australia as well as in south Asia [29-31].

Melioidosis has been described outside the classic endemic regions. Most of such cases are acquired by visitors to endemic areas, with symptoms arising later following departure from the endemic area [32,33]. However, sporadic human or animal cases and occasional environmental isolates of B. pseudomallei have been described from Africa, Indian Ocean countries (such as Mauritius), the Middle East, the Caribbean, and Central and South America [34-36]. Some of these reports represent incorrect species diagnosis, but others have been confirmed as B. pseudomallei, making the endemic boundaries of melioidosis less clear [7,8,37]. As an example, six cases of melioidosis were reported from eastern Puerto Rico between 1982 and 2012 [38]. During investigation of two of those cases, seropositivity to B. pseudomallei was identified in a subset of individuals who lived in proximity to the index patients, and B. pseudomallei was isolated from soil samples from a single site. These findings suggest endemicity of B. pseudomallei in Puerto Rico despite the rarity of reported cases there.

Melioidosis is rare in the United States. Between 2008 and 2013, 34 cases were reported; only three did not have documented travel to an area endemic for melioidosis [39]. Despite extensive investigation, the source of the infection in these three cases could not be identified [40].

                             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Sep 12 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. White NJ. Melioidosis. Lancet 2003; 361:1715.
  2. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383.
  3. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367:1035.
  4. Dance DA. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 2000; 74:159.
  5. Dance DB. Melioidosis. Reviews Med Microbiol 1990; 1:143.
  6. Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 1991; 4:52.
  7. Dance DA. Melioidosis as an emerging global problem. Acta Trop 2000; 74:115.
  8. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 2008; 102 Suppl 1:S1.
  9. Punyagupta S. Melioidosis. Review of 686 cases and presentation of a new clinical classification. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.
  10. Chaowagul W, White NJ, Dance DA, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159:890.
  11. Vuddhakul V, Tharavichitkul P, Na-Ngam N, et al. Epidemiology of Burkholderia pseudomallei in Thailand. Am J Trop Med Hyg 1999; 60:458.
  12. Leelarasamee A. Melioidosis in Southeast Asia. Acta Trop 2000; 74:129.
  13. Puthucheary SD, Lin HP, Yap PK. Acute septicaemic melioidosis: a report of seven cases. Trop Geogr Med 1981; 33:19.
  14. Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 1992; 86:683.
  15. Vadivelu J, Puthucheary SD, Mifsud A, et al. Ribotyping and DNA macrorestriction analysis of isolates of Burkholderia pseudomallei from cases of melioidosis in Malaysia. Trans R Soc Trop Med Hyg 1997; 91:358.
  16. Hassan MR, Pani SP, Peng NP, et al. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis 2010; 10:302.
  17. Chan KW, Jayaratnam FJ, Teo SK. Acute septicaemic melioidosis. A report of three fatal cases. Singapore Med J 1985; 26:382.
  18. Tan AL, Ang BS, Ong YY. Melioidosis: epidemiology and antibiogram of cases in Singapore. Singapore Med J 1990; 31:335.
  19. Yap EH, Chan YC, Goh KT, et al. Sudden unexplained death syndrome--a new manifestation in melioidosis? Epidemiol Infect 1991; 107:577.
  20. Yap EH, Thong TW, Tan AL, et al. Comparison of Pseudomonas pseudomallei from humans, animals, soil and water by restriction endonuclease analysis. Singapore Med J 1995; 36:60.
  21. Singapore Committee on Epidemic Diseases: Melioidosis in Singapore. Epidemiological News Bulletin 1995; 21:69.
  22. Lim MK, Tan EH, Soh CS, Chang TL. Burkholderia pseudomallei infection in the Singapore Armed Forces from 1987 to 1994--an epidemiological review. Ann Acad Med Singapore 1997; 26:13.
  23. Lo TJ, Ang LW, James L, Goh KT. Melioidosis in a tropical city state, Singapore. Emerg Infect Dis 2009; 15:1645.
  24. Currie BJ, Fisher DA, Howard DM, et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 2000; 74:121.
  25. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31:981.
  26. Malczewski AB, Oman KM, Norton RE, Ketheesan N. Clinical presentation of melioidosis in Queensland, Australia. Trans R Soc Trop Med Hyg 2005; 99:856.
  27. Warner J, Learoyd D, Pelowa D, et al. Melioidosis in the Western Province of Papua New Guinea. In: Annual Scientific Meeting, Medical Society of Papua New Guinea, Port Moresby 1998.
  28. Le Hello S, Currie BJ, Godoy D, et al. Melioidosis in New Caledonia. Emerg Infect Dis 2005; 11:1607.
  29. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010; 82:1113.
  30. Saravu K, Mukhopadhyay C, Vishwanath S, et al. Melioidosis in southern India: epidemiological and clinical profile. Southeast Asian J Trop Med Public Health 2010; 41:401.
  31. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010; 4:e900.
  32. Saïdani N, Griffiths K, Million M, et al. Melioidosis as a travel-associated infection: Case report and review of the literature. Travel Med Infect Dis 2015; 13:367.
  33. Dan M. Melioidosis in Travelers: Review of the Literature. Travel Med Infect Dis 2015.
  34. Miralles IS, Maciel Mdo C, Angelo MR, et al. Burkholderia pseudomallei: a case report of a human infection in Ceará, Brazil. Rev Inst Med Trop Sao Paulo 2004; 46:51.
  35. Rolim DB, Vilar DC, Sousa AQ, et al. Melioidosis, northeastern Brazil. Emerg Infect Dis 2005; 11:1458.
  36. Inglis TJ, Rolim DB, Sousa Ade Q. Melioidosis in the Americas. Am J Trop Med Hyg 2006; 75:947.
  37. Dance DA. Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges. Clin Infect Dis 2015; 60:251.
  38. Doker TJ, Sharp TM, Rivera-Garcia B, et al. Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico. Clin Infect Dis 2015; 60:243.
  39. Benoit TJ, Blaney DD, Gee JE, et al. Melioidosis Cases and Selected Reports of Occupational Exposures to Burkholderia pseudomallei--United States, 2008-2013. MMWR Surveill Summ 2015; 64:1.
  40. Stewart T, Engelthaler DM, Blaney DD, et al. Epidemiology and investigation of melioidosis, Southern Arizona. Emerg Infect Dis 2011; 17:1286.
  41. Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med 2015; 36:111.
  42. Sarovich DS, Garin B, De Smet B, et al. Phylogenomic Analysis Reveals an Asian Origin for African Burkholderia pseudomallei and Further Supports Melioidosis Endemicity in Africa. mSphere 2016; 1.
  43. Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016; 1:15008.
  44. Currie BJ, Kaestli M. Epidemiology: A global picture of melioidosis. Nature 2016; 529:290.
  45. Brundage WG, Thuss CJ Jr, Walden DC. Four fatal cases of melioidosis in U. S. soldiers in Vietnam. Bacteriologic and pathologic characteristics. Am J Trop Med Hyg 1968; 17:183.
  46. Mackowiak PA, Smith JW. Septicemic melioidosis. Occurrence following acute influenza A six years after exposure in Vietnam. JAMA 1978; 240:764.
  47. Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis 1971; 124:598.
  48. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11:413.
  49. Currie BJ, Jacups SP. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 2003; 9:1538.
  50. Chierakul W, Winothai W, Wattanawaitunechai C, et al. Melioidosis in 6 tsunami survivors in southern Thailand. Clin Infect Dis 2005; 41:982.
  51. Allworth AM. Tsunami lung: a necrotising pneumonia in survivors of the Asian tsunami. Med J Aust 2005; 182:364.
  52. Athan E, Allworth AM, Engler C, et al. Melioidosis in tsunami survivors. Emerg Infect Dis 2005; 11:1638.
  53. Kunakorn M, Jayanetra P, Tanphaichitra D. Man-to-man transmission of melioidosis. Lancet 1991; 337:1290.
  54. Ralph A, McBride J, Currie BJ. Transmission of Burkholderia pseudomallei via breast milk in northern Australia. Pediatr Infect Dis J 2004; 23:1169.
  55. Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968; 44:599.
  56. Ashdown LR. Nosocomial infection due to Pseudomonas pseudomallei: two cases and an epidemiologic study. Rev Infect Dis 1979; 1:891.
  57. Schlech WF 3rd, Turchik JB, Westlake RE Jr, et al. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 1981; 305:1133.
  58. Sookpranee M, Lumbiganon P, Puapermpoonsiri S, et al. Contamination of Savlon solution with Pseudomonas pseudomallei at Srinagarind Hospital. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.
  59. Sookpranee M, Lumbiganon P, Boonma P. Nosocomial contamination of Pseudomonas pseudomallei in the patients at Srinagarind Hospital. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.
  60. Choy JL, Mayo M, Janmaat A, Currie BJ. Animal melioidosis in Australia. Acta Trop 2000; 74:153.
  61. Stanton AT, Fletcher W. Melioidosis, John Bale and Danielson Ltd, London 1932. Vol 21.
  62. Cottew GS, Sutherland AK, Meehan JF. Melioidosis in sheep in Queensland. Aust Vet J 1952; :113.
  63. Ketterer PJ, Webster WR, Shield J, et al. Melioidosis in intensive piggeries in south eastern Queensland. Aust Vet J 1986; 63:146.
  64. Webling DD. Genito-urinary infections with Pseudomonas pseudomallei in Australian Aboriginals. Trans R Soc Trop Med Hyg 1980; 74:138.
  65. McCormick JB, Sexton DJ, McMurray JG, et al. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med 1975; 83:512.
  66. Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013; 7:e2072.
  67. Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29:408.
  68. Currie BJ, Jacups SP, Cheng AC, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004; 9:1167.
  69. Guard RW, Khafagi FA, Brigden MC, Ashdown LR. Melioidosis in Far North Queensland. A clinical and epidemiological review of twenty cases. Am J Trop Med Hyg 1984; 33:467.
  70. Suputtamongkol Y, Hall AJ, Dance DA, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol 1994; 23:1082.
  71. Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43:979.
  72. Dance DA, Smith MD, Aucken HM, Pitt TL. Imported melioidosis in England and Wales. Lancet 1999; 353:208.
  73. Visca P, Cazzola G, Petrucca A, Braggion C. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 2001; 32:E15.
  74. Holland DJ, Wesley A, Drinkovic D, Currie BJ. Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis 2002; 35:e138.
  75. O'Carroll MR, Kidd TJ, Coulter C, et al. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax 2003; 58:1087.
  76. Geake JB, Reid DW, Currie BJ, et al. An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulm Med 2015; 15:116.
  77. Ruchin P, Robinson J, Segasothy M, Morey F. Melioidosis in a patient with idiopathic pulmonary haemosiderosis resident in Central Australia. Aust N Z J Med 2000; 30:395.
  78. Tarlow MJ, Lloyd J. Melioidosis and chronic granulomatous disease. Proc R Soc Med 1971; 64:19.
  79. Dance DA, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis 1989; 159:654.
  80. Lumbiganon P, Viengnondha S. Clinical manifestations of melioidosis in children. Pediatr Infect Dis J 1995; 14:136.
  81. Edmond K, Currie B, Brewster D, Kilburn C. Pediatric melioidosis in tropical Australia. Pediatr Infect Dis J 1998; 17:77.
  82. McLeod C, Morris PS, Bauert PA, et al. Clinical presentation and medical management of melioidosis in children: a 24-year prospective study in the Northern Territory of Australia and review of the literature. Clin Infect Dis 2015; 60:21.
  83. Fong SM, Wong KJ, Fukushima M, Yeo TW. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia. Clin Infect Dis 2015; 60:1802.
  84. Cheng AC, Wuthiekanun V, Limmathurotsakul D, et al. Intensity of exposure and incidence of melioidosis in Thai children. Trans R Soc Trop Med Hyg 2008; 102 Suppl 1:S37.
  85. NIGG C. SEROLOGIC STUDIES ON SUBCLINICAL MELIOIDOSIS. J Immunol 1963; 91:18.
  86. Strauss JM, Alexander AD, Rapmund G, et al. Melioidosis in Malaysia. 3. Antibodies to Pseudomonas pseudomallei in the human population. Am J Trop Med Hyg 1969; 18:703.
  87. Ashdown LR, Guard RW. The prevalence of human melioidosis in Northern Queensland. Am J Trop Med Hyg 1984; 33:474.
  88. Kanaphun P, Thirawattanasuk N, Suputtamongkol Y, et al. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J Infect Dis 1993; 167:230.
  89. Wuthiekanun V, Chierakul W, Langa S, et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 2006; 74:1074.
  90. Currie BJ, Fisher DA, Anstey NM, Jacups SP. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000; 94:301.
  91. Achana V, Silpapojakul K, Thininta W, Kalnaowakul S. Acute Pseudomonas pseudomallei pneumonia and septicemia following aspiration of contaminated water: a case report. Southeast Asian J Trop Med Public Health 1985; 16:500.
  92. Lee N, Wu JL, Lee CH, Tsai WC. Pseudomonas pseudomallei infection from drowning: the first reported case in Taiwan. J Clin Microbiol 1985; 22:352.
  93. Bovornkitti S, Leelarasamee A, Thamlikitkul V. Melioidosis. Arch Monaldi 1985; 40:203.
  94. Chodimella U, Hoppes WL, Whalen S, et al. Septicemia and suppuration in a Vietnam veteran. Hosp Pract (1995) 1997; 32:219.
  95. Mays EE, Ricketts EA. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest 1975; 68:261.
  96. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005; 43:970.
  97. Newland RC. Chronic melioidosis: a case in Sydney. Pathology 1969; 1:149.
  98. Kingston CW. Chronic or latent melioidosis. Med J Aust 1971; 2:618.
  99. Clayton AJ, Lisella RS, Martin DG. Melioidosis: a serological survey in military personnel. Mil Med 1973; 138:24.
  100. Thatrimontrichai A, Maneenil G. Neonatal melioidosis: systematic review of the literature. Pediatr Infect Dis J 2012; 31:1195.
  101. Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 2003; 22:542.
  102. Simpson AJ, Suputtamongkol Y, Smith MD, et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29:381.
  103. Meumann EM, Cheng AC, Ward L, Currie BJ. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 2012; 54:362.
  104. Gibney KB, Cheng AC, Currie BJ. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis 2008; 47:603.
  105. Kan SK, Kay RW. Melioidosis presenting as prostatitis--a case report from Sabah. Trans R Soc Trop Med Hyg 1978; 72:522.
  106. Woo ML, Chan PS, French GL. A case of melioidosis presenting with prostatic abscess in Hong Kong. J Urol 1987; 137:120.
  107. Morse LP, Moller CC, Harvey E, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol 2009; 182:542.
  108. Subhadrabandhu T, Prichasuk S, Sathapatayavongs B. Localised melioidotic osteomyelitis. J Bone Joint Surg Br 1995; 77:445.
  109. Popoff I, Nagamori J, Currie B. Melioidotic osteomyelitis in northern Australia. Aust N Z J Surg 1997; 67:692.
  110. Woods ML 2nd, Currie BJ, Howard DM, et al. Neurological melioidosis: seven cases from the Northern Territory of Australia. Clin Infect Dis 1992; 15:163.
  111. Currie BJ, Fisher DA, Howard DM, Burrow JN. Neurological melioidosis. Acta Trop 2000; 74:145.
  112. Sarovich DS, Price EP, Webb JR, et al. Variable virulence factors in Burkholderia pseudomallei (melioidosis) associated with human disease. PLoS One 2014; 9:e91682.
  113. St John JA, Walkden H, Nazareth L, et al. Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation. Infect Immun 2016; 84:2681.
  114. Steinmetz I, Stosiek P, Hergenröther D, Bär W. Melioidosis causing a mycotic aneurysm. Lancet 1996; 347:1564.
  115. Lee SS, Liu YC, Wang JH, Wann SR. Mycotic aneurysm due to Burkholderia pseudomallei. Clin Infect Dis 1998; 26:1013.
  116. Torrens JK, McWhinney PH, Tompkins DS. A deadly thorn: a case of imported melioidosis. Lancet 1999; 353:1016.
  117. Low JG, Quek AM, Sin YK, Ang BS. Mycotic aneurysm due to Burkholderia pseudomallei infection: case reports and literature review. Clin Infect Dis 2005; 40:193.
  118. Anunnatsiri S, Chetchotisakd P, Kularbkaew C. Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen. Clin Infect Dis 2008; 47:1436.
  119. Amezyane T, Lecoules S, Algayres JP. Mycotic iliac aneurysm associated with Burkholderia pseudomallei. Int J Infect Dis 2010; 14 Suppl 3:e381.
  120. Ruff MJ, Lamkin N Jr, Braun J, Barnwell P. Melioidosis complicated by pericarditis. Chest 1976; 69:227.
  121. Osteraas GR, Hardman JM, Bass JW, Wilson C. Neonatal melioidosis. Am J Dis Child 1971; 122:446.
  122. Weber DR, Douglass LE, Brundage WG, Stallkamp TC. Acute varieties of melioidosis occurring in U. S. soldiers in Vietnam. Am J Med 1969; 46:234.
  123. Lee SC, Ling TS, Chen JC, et al. Melioidosis with adrenal gland abscess. Am J Trop Med Hyg 1999; 61:34.
  124. Chadwick DR, Ang B, Sitoh YY, Lee CC. Cerebral melioidosis in Singapore: a review of five cases. Trans R Soc Trop Med Hyg 2002; 96:72.
  125. Pagnarith Y, Kumar V, Thaipadungpanit J, et al. Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg 2010; 82:1106.
  126. Jenney AW, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001; 17:109.
  127. Price EP, Sarovich DS, Mayo M, et al. Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio 2013; 4.
  128. Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis 2015; 21.
  129. Ashdown LR. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 1979; 11:293.
  130. Peacock SJ, Chieng G, Cheng AC, et al. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 2005; 43:5359.
  131. Simpson AJ, Howe PA, Wuthiekanun V, White NJ. A comparison of lysis centrifugation, pour plate, and conventional blood culture methods in the diagnosis of septicaemic melioidosis. J Clin Pathol 1999; 52:616.
  132. Dance DA, Wuthiekanun V, Naigowit P, White NJ. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol 1989; 42:645.
  133. Steinmetz I, Reganzerowski A, Brenneke B, et al. Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol 1999; 37:225.
  134. Glass MB, Popovic T. Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2005; 43:479.
  135. Inglis TJ, Merritt A, Chidlow G, et al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol 2005; 43:2201.
  136. Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002; 40:4625.
  137. Amornchai P, Chierakul W, Wuthiekanun V, et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007; 45:3774.
  138. Podin Y, Kaestli M, McMahon N, et al. Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent. J Clin Microbiol 2013; 51:3076.
  139. Cheng AC, O'brien M, Freeman K, et al. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 2006; 74:330.
  140. Appassakij H, Silpapojakul KR, Wansit R, Pornpatkul M. Diagnostic value of the indirect hemagglutination test for melioidosis in an endemic area. Am J Trop Med Hyg 1990; 42:248.
  141. Sirisinha S, Anuntagool N, Dharakul T, et al. Recent developments in laboratory diagnosis of melioidosis. Acta Trop 2000; 74:235.
  142. Zysk G, Splettstösser WD, Neubauer H. A review on melioidosis with special respect on molecular and immunological diagnostic techniques. Clin Lab 2000; 46:119.
  143. Anuntagool N, Naigowit P, Petkanchanapong V, et al. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol 2000; 49:1075.
  144. Samosornsuk N, Lulitanond A, Saenla N, et al. Short report: evaluation of a monoclonal antibody-based latex agglutination test for rapid diagnosis of septicemic melioidosis. Am J Trop Med Hyg 1999; 61:735.
  145. Haase A, Brennan M, Barrett S, et al. Evaluation of PCR for diagnosis of melioidosis. J Clin Microbiol 1998; 36:1039.
  146. Anuntagool A, Intachote P, Naigowit P, Sirisinha S. Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J Clin Microbiol 1996; 34:975.
  147. Smith MD, Wuthiekanun V, Walsh AL, et al. Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis. J Clin Pathol 1995; 48:174.
  148. Wuthiekanun V, Desakorn V, Wongsuvan G, et al. Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol 2005; 12:555.
  149. Meumann EM, Novak RT, Gal D, et al. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol 2006; 44:3028.
  150. Chantratita N, Meumann E, Thanwisai A, et al. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J Clin Microbiol 2008; 46:568.
  151. Cunningham SA, Patel R. Importance of using Bruker's security-relevant library for Biotyper identification of Burkholderia pseudomallei, Brucella species, and Francisella tularensis. J Clin Microbiol 2013; 51:1639.
  152. Houghton RL, Reed DE, Hubbard MA, et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis 2014; 8:e2727.
  153. Tan AP, Pui MH, Tan LK. Imaging patterns in melioidosis. Australas Radiol 1995; 39:260.
  154. Chong VF, Fan YF. The radiology of melioidosis. Australas Radiol 1996; 40:244.